Tag: AV access

APERTO DCB a “very promising new technology” for central vein stenosis

NOTE: This video is ONLY available to watch in selected countries and geographies “Patients who are on chronic dialysis really depend on arteriovenous (AV)...

First-in-human study of Wrapsody cell-impermeable endoprosthesis yields “very promising” results

Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...
trerotola misra tan av access dcbs drug coated balloons

More mixed results for DCBs in AV access maintenance as evidence...

Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...

IN.PACT™ AV Access trial shows improvement in patency “for the entire...

 A trio of vascular experts including Raphaël Coscas (Paris, France), Alexandros Mallios (Paris, France) and Kate Steiner (Stevenage, UK) discuss the key findings of...

Mermaid Medical Group reports full commercialisation of the D-Clot HD rotational...

Mermaid Medical Group recently announced US commercial availability of the D-Clot HD rotational thrombectomy system. As of 12 January, the company reports 25 successful...

New England Journal Of Medicine publishes “outstanding” six-month IN.PACT AV Access™...

NOTE: This video is ONLY available to watch in selected countries and geographies Robert Lookstein (New York, USA; principal investigator) and Andrew Holden (Auckland,...

Impressions from LINC 2020: Strong clinical and economic case for widespread...

NOTE: This video is ONLY available to watch in selected countries and geographies Andrew Holden (Auckland, New Zealand), Alexandros Mallios (Paris, France), Robert Lookstein (New...
Panel at LINC Tuesday MEDTRONIC

LINC 2020: One year IN.PACT AV results show sustained patency benefit...

NOTE: This video is ONLY available to watch in selected countries and geographies  The one-year IN.PACT AV trial results, first presented at LINC 2020 (28–31 January, Leipzig,...

A panel of experts comments on IN.PACT AV ACCESS data

NOTE: This video is ONLY available to watch in selected countries and geographies   Jos van den Berg (Lugano, Switzerland) speaks to Andrew Holden (Auckland, New...
VasQ

First patients enrolled in US pivotal trial of the VasQ device

The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device...

TVA Medical receives CE mark for everlinQ 4 endovascular AVF system

TVA Medical’s everlinQ 4 endovascular arteriovenous fistula (AVF) system has received CE mark in the European Union. The technology uses a 4F catheter system...

Bard gets FDA premarket approval of the Lutonix 035 DCB for...

Bard’s Lutonix 035 drug-coated balloon PTA catheter (DCB) has been granted premarket approval (PMA) by the US Food and Drug Administration (FDA) for a...

Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous...

Scott Trerotola presented the first release of eight-month data from the Lutonix AV trial at the Leipzig Interventional Course (LINC; 24–27 January, Leipzig, Germany)...

Mechanical approaches to improving AV fistula outcomes

Although arteriovenous (AV) fistulae are considered the gold standard for vascular access for haemodialysis and have a low rate of complications and improved longevity...

Promising early results for Lutonix US IDE trial in obstructed AV...

The first US randomised controlled trial for drug-coated balloon use for arteriovenous fistula obstructions for 50 years, the Lutonix (Bard) IDE trial was a...

Merit Medical launches Super HeRO and HeRO Ally products

Merit Medical Systems has announced the launch of the proprietary Super HeRO and HeRO Ally products, additions to Merit’s expanding portfolio of dialysis access...

NEAT trial shows six times fewer post-creation interventions with endovascular than...

NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...

New developments in dialysis grafts

With the rising incidence of haemodialysis worldwide, there is an ever-increasing need for creative, durable means of access. The National Kidney Foundation and Centers...

Gore Viabahn endoprosthesis celebrates 20 years since introduction

Gore is celebrating the 20th anniversary of the introduction of the Viabahn endoprosthesis; its stent graft for the treatment of complex peripheral vascular disease....